Submitted by Anonymous (not verified) on 23 April 2026 - 12:09
Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 47, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 47, Status: Authorised